Project Grant R01DK149150
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $847,498 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate strategies for integrating deceased-donor-initiated kidney paired donation (DD-KPD) chains into the U.S. kidney allocation system. The project addresses the kidney shortage and stagnation in living donation by redirecting a small percentage of deceased...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $2,557,884 on September 10, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a detailed analysis of long-term health outcomes in living kidney donors using real-world electronic health records. The recipient will analyze the COSMOS dataset, which encompasses electronic health records from over 245 million individuals...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University (doing business as New York University School of Medicine) $1.674 million on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an empirically-based, optimal prehabilitation program for kidney transplant candidates on hemodialysis. The research addresses a significant clinical need: of more than 140,000 people waiting for kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $872,273 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify modifiable process delays in deceased donor kidney allocation through process mining analysis. The project applies process mining methodology to discover actual kidney placement workflows from data logs at multiple organ procurement organizations (OPOs). The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $847,495 on February 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to build expert consensus on stratified kidney allocation design, estimate the policy impact of stratified allocation systems to assist policymakers, and investigate patient, care partner, and provider attitudes and perceptions regarding shared decision-making...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $1.65 million on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate and design a new kidney allocation policy permitting ABO-compatible transplants. The research addresses a persistent gap in the current U.S. kidney allocation system: high-sensitized patients with blood types B and O remain underserved despite the 2014 policy...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $327,479 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a formative intervention adaptation and small-scale pilot randomized controlled trial of Project ANCHOR, a supportive care intervention for family caregivers of patients awaiting kidney transplantation. Project ANCHOR employs a telehealth coaching approach consisting...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Washington University $766,951 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate imaging biomarkers for assessing high-risk deceased donor kidneys slated for transplantation. The project addresses kidney shortage by improving the accuracy of kidney quality assessment, reducing the approximately 2,500 procured kidneys discarded...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $1.693 million on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop individualized immunosuppression regimens for kidney transplant recipients using machine learning and electronic health record data. The project addresses a clinical gap in immunosuppressive therapy optimization. Over 250,000 kidney transplant recipients depend...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California, Irvine a $229,553 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 1, 2025, and concluding August 31, 2027. This mixed-methods research study will investigate non-clinical donor factors affecting post-donation follow-up care for living kidney donors and evaluate telemedicine...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $877,742 on September 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the effect of a state-wide centralized patient coaching program about live donor kidney transplantation. The award funds the Live Donor Champion (LDC) program, which educates end-stage kidney disease patients, their caregivers, and social networks about the benefits of kidney transplantation and living donation. The program is designed to increase access to live donor kidney transplantation, which doubles expected graft survival for recipients compared with deceased donor transplantation. Pre- and post-program data indicate participants increased knowledge scores from 63 percent to 83 percent on a twelve-question quiz. Work is performed in New York, New York. The period of performance runs through April 30, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $877.7k | 9/2/26 |